PALAZESTRANT

UNII:	VU35KM56Q4
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₈H₃₆FN₃O
Preferred Substance Name:	PALAZESTRANT
InChIKey:	LBSFUBLFDCAEKV-XHCCPWGMSA-N
GSRS Full Record:	VU35KM56Q4 i

2092925-89-6
(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1-[4-(1-propylazetidin-3-yl)oxyphenyl]-1,3,4,9-tetrahydropyrido[3,4-b]indole
(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1-{4-[(1-propylazetidin-3- yl)oxy]phenyl}-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole
1H-Pyrido[3,4-b]indole, 2-(2-fluoro-2-methylpropyl)-2,3,4,9-tetrahydro-3-methyl-1-[4-[(1-propyl-3-azetidinyl)oxy]phenyl]-, (1R,3R)-
OP-1250
PALAZESTRANT [USAN]
Palazestrant
Palazestrant [WHO-DD]
palazestrant [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PALAZESTRANT

Synonyms and Mappings

Resources